NCT05273047View on ClinicalTrials.gov

RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC

UnknownOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

August 30, 2023

Study Completion Date

December 31, 2024

Conditions
NsclcKRAS P.G12C
Trial Locations (3)

Unknown

Paris - Hôpital Cochin, Paris

Rouen - CHU, Rouen

Strasbourg - CHU, Strasbourg

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER